 |
English
|
正體中文
|
简体中文
|
Items with full text/Total items : 17938/22957 (78%)
Visitors : 7390616
Online Users : 201
|
|
|
Items for Author "Hsu, KH"
Return to Browse by Author
Showing 10 items.
|
Collection |
Date |
Title |
Authors |
Bitstream |
| [中山醫學大學研究成果] 期刊論文 |
2021 |
The impact of different first-line EGFR-TKIs on the clinical outcome of sequential osimertinib treatment in advanced NSCLC with secondary T790M |
Huang, YH; Tseng, JS; Hsu, KH; Chen, KC; Su, KY; Yu, SL; Chen, JJW; Yang, TY; Chang, GC |
 |
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment |
Tseng, JS; Hsu, KH; Zheng, ZR; Yang, TY; Chen, KC; Huang, YH; Su, KY; Yu, SL; Chang, GC |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors |
Lee, PH; Yang, TY; Chen, KC; Huang, YH; Jeng-Sen Tseng; Hsu, KH; Wu, YC; Liu, KJ; Chang, GC |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma <= 2 cm in size: A retrospective cohort study |
Wu, JJ; Wu, CY; Wu, CY; Wang, CL; Yang, TY; Tseng, JS; Hsu, KH; Huang, YH; Hsu, CP; Chuang, CY; Lin, CH; Tseng, CH; Chen, KC; Chang, GC |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non-small cell lung cancer patients |
Lee, PH; Chen, KC; Hsu, KH; Huang, YH; Tseng, JS; Yang, TY; Chang, GC |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients |
Hsu, KH; Huang, JW; Tseng, JS; Chen, KW; Weng, YC; Yu, SL; Yang, TY; Huang, YH; Chen, JJ; Chen, KC; Chang, GC |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
Genome-Wide Epigenetic Landscape of Lung Adenocarcinoma Links HOXB9 DNA Methylation to Intrinsic EGFR-TKI Resistance and Heterogeneous Response |
Su, SF; Liu, CH; Cheng, CL; Ho, CC; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chen, HW; Chang, GC; Yu, SL; Li, KC |
|
| [中山醫學大學研究成果] 期刊論文 |
2021 |
The relative importance of predictive factors for single first-generation EGFR-TKI use for more than 5 years in patients with advanced non-small cell lung cancer: Taiwan multicenter TIPS-5 study |
Huang, YH; Hung, JY; Ko, HW; Su, PL; Lai, CL; Chang, HC; Hsia, TC; Lin, SH; Wu, KL; Yang, CT; Su, WC; Chu, YC; Wang, CC; Liao, WY; Lin, YT; Lin, CH; Lin, MC; Hsu, KH; Tseng, JS; Yang, TY; Chen, KC; Lee, MH; Yu, SL; Ho, CC; Chang, GC |
|
| [中山醫學大學研究成果] 期刊論文 |
2020 |
ALK variants, PD-L1 expression, and their association with outcomes in ALK-positive NSCLC patients |
Chang, GC; Yang, TY; Chen, KC; Hsu, KH; Huang, YH; Su, KY; Yu, SL; Tseng, JS |
|
| [中山醫學大學研究成果] 期刊論文 |
2020 |
Landscape of Mitochondria Genome and Clinical Outcomes in Stage 1 Lung Adenocarcinoma |
Raghav, L; Chang, YH; Hsu, YC; Li, YC; Chen, CY; Yang, TY; Chen, KC; Hsu, KH; Tseng, JS; Chuang, CY; Lee, MH; Wang, CL; Chen, HW; Yu, SL; Su, SF; Yuan, SS; Chen, JJW; Ho, SY; Li, KC; Yang, PC; Chang, GC; Chen, HY |
|
|
